Original Articles

Comparison of the Diagnostic Accuracy of the Xpert MTB/RIF Assay with Acid-Fast Staining and Culture Methods for Prompt Detection of Mycobacterium tuberculosis Isolates

Abstract

Background:   The aim of this study was to compare the diagnostic accuracy of the GeneXpert with acid-fast stain (AFB) and culture methods in patients with suspected pulmonary tuberculosis (SPT).

Methods:    A total of 484 sputum and BALF (bronchoalveolar lavage fluid). Samples were analyzed from 428 individuals, of which 78.3% were men and the average age was 49.9 years.

Results:   The GeneXpert test had a sensitivity of 95.7% and a specificity of 43.9% for MTB culture, and a sensitivity of 91.9% and a specificity of 52.8% for a definitive diagnosis. The sample had a sensitivity of 93.7%, specificity of 69.6%, and accuracy of 82.2% for MTB culture, and sensitivity of 86.9%, specificity of 82.2%, and accuracy of 85.3% for the final diagnosis. Overall, the AFB exam had the highest diagnostic accuracy of the three tests at 85.3%.

Conclusion:   The study indicates that while the study's AFB test is usually used as the first diagnostic test for pulmonary TB due to its high accuracy, the GeneXpert test can be used in samples that are AFB negative, but strongly suspected for TB, because it has a higher sensitivity. Choosing the appropriate test based on the clinical context is critical for accurate diagnosis and treatment of TB.

1. Meskini M, Madadi N, Ahmadi K, et al. Tuberculosis prevention, diagnosis, and treatment financial profile during 2006–2021: PART A. Cost Eff Res Alloc 2023; 211:68.
2. Abbasian S, Heidari H, Kardan-Yamchi J, et al. Epidemiology of first-and second-line drugs-resistant pulmonary tuberculosis in Iran: Systematic review and meta-analysis. J Clin Tuberc Other Mycobact Dis 2024; 16(35):100430.
3. Jafari A, Goswami R, Aski HS, et al. Evaluation of accuracy of microplate alamar blue assay and proportion method for prompt detection of Mycobacterium tuberculosis and clinical isolates of multidrug-resistant M. tuberculosis. Jundishapur J Microbiol 2021; 14(3).
4. Kasper DFA, Hauser S, Longo D, et al. Harrison's principles of internal medicine. 21 ed. 2022: Mcgraw-hill New York, NY, USA.
5. Sharma SK, Kohli M, Yadav RN, et al. Evaluating the diagnostic accuracy of Xpert MTB/RIF assay in pulmonary tuberculosis. PloSOne 2015; 10(10):e0141011.
6. Lawn SD, Zumla AI. Diagnosis of extra-pulmonary tuberculosis using the Xpert® MTB/RIF assay. Expert Rev Anti Infect Ther 2012; 106:631-5.
7. Lawn SD, Mwaba P, Bates M, et al. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis 2013; 134:349-61.
8. Kilaru SC, Chenimilla NP, Syed U, et al. Role of Xpert MTB/RIF in bronchoalveolar lavage fluid of sputum-scarce, suspected pulmonary TB patients. J Clin Tuberc Other Mycobact Dis 2019; 14:7-11.
9. Bajrami R, Mulliqi G, Kurti A, et al. Assessment of diagnostic accuracy of GeneXpert Mycobacterium tuberculosis/rifampicin in diagnosis of pulmonary tuberculosis in Kosovo. Biomed Biotechnol Res J 2018; 23:191-5.
10. Bialvaei AZ, Asgharzadeh M, Aghazadeh M, et al. Challenges of tuberculosis in Iran. Jundishapur J Microbiol 2017; 10(3):
11. Patel J, Upadhyay M, Kundnani V, et al. Diagnostic efficacy, sensitivity, and specificity of Xpert MTB/RIF assay for spinal tuberculosis and rifampicin resistance. Spine 2020; 453:163-9.
12. Rimal R, Shrestha D, Pyakurel S, et al. Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients. BMC Infect Dis 2022; 221:321.
13. Organization W H, Global tuberculosis report 2020. 2020: World Health Organization.
14. Zetola NM, Shin SS, Tumedi KA, et al. Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes. J Clin Microbiol 2014; 527:2422-9.
15. Friedrich SO, Rachow A, Saathoff E, et al. Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment. Lancet Respir Med 2013; 16:462-70.
16. Kabir S, Parash M TH, Emran NA, et al. Diagnostic challenges and Gene-Xpert utility in detecting Mycobacterium tuberculosis among suspected cases of Pulmonary tuberculosis. PLoSOne 2021; 165:e0251858.
17. Biset S, Teferi M, Alamirew H, et al. Trends of Mycobacterium tuberculosis and rifampicin resistance in Northwest Ethiopia: Xpert® MTB/RIF assay results from 2015 to 2021. BMC Infect Dis 2024; 241:238.
18. Rasheed W, Rao NA, Adel H, Bet al. Diagnostic accuracy of Xpert MTB/RIF in sputum smear-negative pulmonary tuberculosis. Cureus 2019; 15(11):8.
Files
IssueVol 13 No 2 (2025) QRcode
SectionOriginal Articles
DOI https://doi.org/10.18502/jmb.v13i2.18658
Keywords
Acid-fast staining Culture Mycobacterium tuberculosis Xpert MTB/RIF test.
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Momeni N, Mahfoozi L, Maroufizadeh S, Karimian P, Hesni E. Comparison of the Diagnostic Accuracy of the Xpert MTB/RIF Assay with Acid-Fast Staining and Culture Methods for Prompt Detection of Mycobacterium tuberculosis Isolates. J Med Bacteriol. 2025;13(2):63-71.